STAT5B and diabetes mellitus: To validate the capacity of tolerogenic Stat5b-CA.BMDCs to induce antigen-specific immune tolerance in vivo, we investigated their ability to induce immune tolerance in an autoimmune disease setting such as halting ongoing autoimmune diabetes in diabetes-prone NOD mice.